10843002: Anterior pituitary hormone (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\Pituitary hormone\Anterior pituitary hormone

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hormone\Pituitary hormone\Anterior pituitary hormone

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

18833017 Anterior pituitary hormone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

600665019 Anterior pituitary hormone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

7040411000241116 hormone de l'hypophyse antérieure fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

7040421000241111 hormone hypophysaire antérieure fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Anterior pituitary hormone	Is a	Pituitary hormone	false	Inferred relationship	Some
Anterior pituitary hormone	Is a	Hypothalamic or pituitary hormone	false	Inferred relationship	Some
Anterior pituitary hormone	Is a	Pituitary hormone	false	Inferred relationship	Some
Anterior pituitary hormone	Is a	Pituitary hormone	true	Inferred relationship	Some
Anterior pituitary hormone	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Anterior pituitary hormone (disposition)	true	Inferred relationship	Some
Anterior pituitary hormone	Is a	hormones et leurs métabolites et précurseurs	false	Inferred relationship	Some
Anterior pituitary hormone	Is a	Substance categorized by disposition	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Pituitary gonadotropin	Is a	True	Anterior pituitary hormone	Inferred relationship	Some
Adrenocorticotropic hormone	Is a	False	Anterior pituitary hormone	Inferred relationship	Some
Thyrotrophin	Is a	True	Anterior pituitary hormone	Inferred relationship	Some
Human growth hormone	Is a	False	Anterior pituitary hormone	Inferred relationship	Some
Poisoning caused by combination analgesic of undetermined intent	Causative agent (attribute)	False	Anterior pituitary hormone	Inferred relationship	Some
Accidental corticotrophin poisoning (disorder)	Causative agent (attribute)	False	Anterior pituitary hormone	Inferred relationship	Some
Intentional corticotrophin poisoning (disorder)	Causative agent (attribute)	False	Anterior pituitary hormone	Inferred relationship	Some
Corticotrophin poisoning of undetermined intent	Causative agent (attribute)	False	Anterior pituitary hormone	Inferred relationship	Some
Accidental gonadotrophin poisoning	Causative agent (attribute)	False	Anterior pituitary hormone	Inferred relationship	Some
Intentional gonadotrophin poisoning	Causative agent (attribute)	False	Anterior pituitary hormone	Inferred relationship	Some
Gonadotrophin poisoning of undetermined intent	Causative agent (attribute)	False	Anterior pituitary hormone	Inferred relationship	Some
Accidental somatotrophin poisoning	Causative agent (attribute)	False	Anterior pituitary hormone	Inferred relationship	Some
Intentional somatotrophin poisoning	Causative agent (attribute)	False	Anterior pituitary hormone	Inferred relationship	Some
Somatotrophin poisoning of undetermined intent	Causative agent (attribute)	False	Anterior pituitary hormone	Inferred relationship	Some
Poisoning caused by somatotropin	Causative agent (attribute)	False	Anterior pituitary hormone	Inferred relationship	Some
Poisoning by corticotropin	Causative agent (attribute)	False	Anterior pituitary hormone	Inferred relationship	Some
Poisoning by anterior pituitary hormone	Causative agent (attribute)	True	Anterior pituitary hormone	Inferred relationship	Some	1
Poisoning caused by oxytocic agent	Causative agent (attribute)	False	Anterior pituitary hormone	Inferred relationship	Some
Poisoning by gonadotropin	Causative agent (attribute)	False	Anterior pituitary hormone	Inferred relationship	Some
Intentional combined analgesic overdose	Causative agent (attribute)	False	Anterior pituitary hormone	Inferred relationship	Some
Anterior pituitary hormone poisoning NOS	Causative agent (attribute)	False	Anterior pituitary hormone	Inferred relationship	Some
Oxytocic agent poisoning NOS	Causative agent (attribute)	False	Anterior pituitary hormone	Inferred relationship	Some
Corticotropin preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Product containing melatonin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Corticotrophins	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (efficacité biologique relative) 1,8 UI (0,6 mg), seringue préremplie de poudre et solvant pour solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (efficacité biologique relative) 1,2 UI (0,4 mg), seringue préremplie de poudre et solvant pour solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (efficacité biologique relative) 0,6 UI (0,2 mg), seringue préremplie de poudre et solvant pour solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (rmc) 24 UI (8 mg), fiole de poudre et solvant pour solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (efficacité biologique relative) 16 UI (5,33 mg), poudre et diluant pour injection avec nécessaire de reconstitution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (efficacité biologique relative) 12 UI (4 mg), fiole de poudre et solvant pour solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (efficacité biologique relative) 2,4 UI (0,8 mg), seringue préremplie de poudre et solvant pour solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (efficacité biologique relative) 3 UI (1 mg), seringue préremplie de poudre et solvant pour solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (efficacité biologique relative) 16 UI (5,33 mg), cartouche de poudre pour solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (efficacité biologique relative) 16 UI (5,33 mg), fiole de poudre et solvant pour solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (rmc) 10 UI (3,33 mg), fiole de poudre et solvant pour solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (rmc) 4 UI (1,33 mg), fiole de poudre et solvant pour solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (efficacité biologique relative) 4 UI (1,33 mg), fiole de poudre et solvant pour solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 12 mg powder for solution for injection cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (efficacité biologique relative) 18 UI (6 mg), cartouche de poudre et solvant pour solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (efficacité biologique relative) 36 UI (12 mg), cartouche de poudre et solvant pour solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (efficacité biologique relative) 72 UI (24 mg), cartouche de poudre et solvant pour solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (efficacité biologique relative) 3,6 UI (1,2 mg), seringue préremplie de poudre et solvant pour solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (efficacité biologique relative) 4,2 UI (1,4 mg), seringue préremplie de poudre et solvant pour solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (efficacité biologique relative) 4,8 UI (1,6 mg), seringue préremplie de poudre et solvant pour solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (efficacité biologique relative) 5,4 UI (1,8 mg), seringue préremplie de poudre et solvant pour solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (efficacité biologique relative) 6 UI (2 mg), seringue préremplie de poudre et solvant pour solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (epr) 3,33 mg/mL, cartouche de 1,5 mL de solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (epr) 6,66 mg/mL, cartouche de 1,5 mL de solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
somatropine (epr) 10 mg/mL, cartouche de 1,5 mL de solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatrophic hormone	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Human growth hormone recombinant preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Product containing somatotropin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Anterior pituitary extract preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Product containing corticotropin releasing factor (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Product containing somatropin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin [2]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 10mg/vial solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 10mg/2mL solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 1.6mg powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 1.2mg powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 2mg powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 0.8mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 2.0mg/.25mL powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 13.8mg powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 1.5mg powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 1.4mg powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 0.2mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 5.8mg powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 1.4mg/.25mL powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 1.6mg/.25mL powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 1.2mg/.25mL powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 0.8mg/unit powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 0.6mg/unit powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 1.8mg powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 0.44mg/unit powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 1.8mg/.25mL powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 1.0mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 0.4mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Product containing anterior pituitary hormone (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Anterior pituitary hormone	Inferred relationship	Some	1
Somatropin 12mg/vial powder for injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 0.6mg/vial powder for injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 15mg/1.5mL injection solution 1.5mL cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 5.0mg/1.5mL injection solution 1.5mL cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 5mg/vial powder for injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 10mg/vial powder for injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 6mg/vial powder for injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 10.0mg/1.5mL injection solution 1.5mL cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 4mg/vial powder for injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 8.8mg/vial powder for injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 13.5mg/3mL injection solution 3mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 18mg/3mL injection solution 3mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin 22.5mg/3mL injection solution 3mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Somatropin(rbe) 5mg(15iu)/mL injection solution 2mL cartridge	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Bovine growth hormone recombinant preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Sometribove preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Corticotropin 80units/mL in gelatin injection solution 5mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Anterior pituitary hormone	Inferred relationship	Some
Bovine growth hormone	Is a	True	Anterior pituitary hormone	Inferred relationship	Some
Somatropin (substance)	Is a	True	Anterior pituitary hormone	Inferred relationship	Some
Accidental gonadotrophin poisoning	Causative agent (attribute)	False	Anterior pituitary hormone	Inferred relationship	Some
Intentional gonadotrophin poisoning	Causative agent (attribute)	False	Anterior pituitary hormone	Inferred relationship	Some

Page 1 of 2 End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
18833017	Anterior pituitary hormone	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
600665019	Anterior pituitary hormone (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
7040411000241116	hormone de l'hypophyse antérieure	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
7040421000241111	hormone hypophysaire antérieure	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module